Physiotherapy in Emergency Department for Acute Lumbar Spasm

NCT ID: NCT06987656

Last Updated: 2025-09-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-01

Study Completion Date

2025-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective observational study aims to evaluate the effectiveness of physiotherapy interventions-such as manual therapy, electrotherapy (TENS), and individualized exercise programs-in managing acute lumbar spasm in patients presenting to the emergency department. By analyzing medical records from January to June 2024 at Düzce University Faculty of Medicine, the study will compare outcomes between patients receiving only pharmacological treatment and those receiving additional physiotherapy. Primary outcomes include changes in pain levels (measured by Visual Analog Scale), medication usage, patient satisfaction, and re-admission rates within an 8-week follow-up period. The findings aim to inform the integration of physiotherapy into emergency care protocols for acute lumbar spasm.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This retrospective observational study investigates the role of physiotherapy in managing acute lumbar spasm in emergency department settings. The study will review medical records of 100 patients aged 18 to 65 who presented to Düzce University Faculty of Medicine Emergency Department between January and June 2024 with non-specific acute low back spasm.

Patients will be divided into two groups based on documented treatment: (1) those receiving pharmacological treatment only, and (2) those receiving both pharmacological and physiotherapy interventions. Physiotherapy interventions include spinal mobilization, myofascial release, TENS (Transcutaneous Electrical Nerve Stimulation), and individualized exercise protocols.

Primary outcomes include changes in pain intensity (measured by Visual Analog Scale), medication consumption, re-admission rates within 8 weeks, and overall patient satisfaction. The study also incorporates a cost analysis based on national reimbursement tariffs (SUT) to evaluate the financial impact of integrating physiotherapy into emergency care.

This study does not involve any direct intervention, and data are collected exclusively from existing electronic health records. Ethical approval has been obtained. The findings are expected to guide future protocols involving the integration of physiotherapy into emergency departments in Turkey.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Low Back Pain Musculoskeletal Pain Emergency Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pharmacologic Treatment Only Group

Patients who received standard pharmacologic treatment only, including NSAIDs, muscle relaxants, and analgesics, without any physiotherapy intervention.

Standard Pharmacologic Treatment

Intervention Type DRUG

Standard pharmacologic management including nonsteroidal anti-inflammatory drugs (NSAIDs), muscle relaxants (e.g., thiocolchicoside), and analgesics (e.g., paracetamol, tramadol) for acute lumbar spasm.

Pharmacologic + Physiotherapy Group

Patients who received standard pharmacologic treatment along with physiotherapy interventions, including spinal mobilization, electrotherapy (TENS), and individualized exercise programs.

Standard Pharmacologic Treatment

Intervention Type DRUG

Standard pharmacologic management including nonsteroidal anti-inflammatory drugs (NSAIDs), muscle relaxants (e.g., thiocolchicoside), and analgesics (e.g., paracetamol, tramadol) for acute lumbar spasm.

Physiotherapy Intervention

Intervention Type OTHER

Physiotherapy interventions included spinal mobilization (Maitland techniques), myofascial release, transcutaneous electrical nerve stimulation (TENS), and personalized exercise programs, as documented in patient medical records.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard Pharmacologic Treatment

Standard pharmacologic management including nonsteroidal anti-inflammatory drugs (NSAIDs), muscle relaxants (e.g., thiocolchicoside), and analgesics (e.g., paracetamol, tramadol) for acute lumbar spasm.

Intervention Type DRUG

Physiotherapy Intervention

Physiotherapy interventions included spinal mobilization (Maitland techniques), myofascial release, transcutaneous electrical nerve stimulation (TENS), and personalized exercise programs, as documented in patient medical records.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged between 18 and 65 years
* Presented to the emergency department with non-specific acute lumbar spasm
* No serious pathology on initial evaluation (e.g., infection, malignancy, fracture)
* No contraindications to physiotherapy or physical activity
* Agreed to participate in the study and signed the informed consent (if applicable in prospective cases)

Exclusion Criteria

* History of chronic low back pain
* Presence of neurological deficits (e.g., paresis, paralysis)
* Diagnosed with serious medical conditions such as infection, malignancy, or spondylodiscitis
* Pregnancy or contraindications related to reproductive health
* History of spinal surgery within the past year
* Cognitive or physical impairments limiting treatment participation
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ankara Yildirim Beyazıt University

OTHER

Sponsor Role collaborator

Duzce University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Veysel Uludag

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duzce University

Düzce, Düzce, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/254

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.